Improve Medical Instruments Co., Ltd. (SHE:300030)
China flag China · Delayed Price · Currency is CNY
5.97
-0.14 (-2.29%)
Oct 28, 2026, 1:55 PM CST

SHE:300030 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
9.3514.53-117.9-63.2-198.318.57
Depreciation & Amortization
33.9633.9639.8545.1346.7553.31
Other Amortization
1.981.982.033.582.672.63
Loss (Gain) From Sale of Assets
-2.09-2.09-0.9-6.45-0.44-0.02
Asset Writedown & Restructuring Costs
22.622.623.338.9990.081.39
Loss (Gain) From Sale of Investments
-10.31-10.3163.56-7.4453.1-19.34
Provision & Write-off of Bad Debts
-5.28-5.2823.96-3.089.17.75
Other Operating Activities
24.7717.2534.5247.9253.4744.18
Change in Accounts Receivable
141.92141.9219.652.76-12.59109.82
Change in Inventory
9.129.12-0.09-19.77-16.14-15.78
Change in Accounts Payable
-117.32-117.32-1.926.9738.21-32.99
Operating Cash Flow
112.24109.981.8479.942.48171.74
Operating Cash Flow Growth
1.68%34.29%2.42%88.11%-75.27%21.56%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-29.49-24.12-51.28-43.7-58.04-71.05
Sale of Property, Plant & Equipment
1.121.5837.513.60.060.13
Divestitures
----26.62.71
Investment in Securities
10.9128.35-20-13.255.79
Other Investing Activities
35.3826.52-1.0821.59-22.62
Investing Cash Flow
17.914.9813.5-38.5-44.64-39.81

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Long-Term Debt Issued
-231.4354.73393.58381.99272.62
Long-Term Debt Repaid
--425.99-405.57-425.18-467.2-250.39
Lease Payments
-2.92-2.92-6.05-10.18-8.6-12.51
Net Debt Issued (Repaid)
-139.79-194.59-50.84-31.6-85.2122.24
Issuance of Common Stock
--0.03--9.91
Common Dividends Paid
-8.05-5.5-11.97-15.94-37.67-31.14
Other Financing Activities
0.35-3.232.14-2.562.05-3.57
Financing Cash Flow
-147.49-203.32-60.63-50.09-120.83-2.57

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-1.210.321.230.610.98-0.88
Net Cash Flow
-18.55-88.1335.94-8.08-122.01128.49

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
82.7585.7730.5536.2-15.56100.69
Free Cash Flow Growth
-8.54%180.72%-15.60%--19.22%
Free Cash Flow Margin
16.53%17.64%5.26%5.62%-2.19%12.59%
Free Cash Flow Per Share
0.280.290.100.12-0.050.33
Levered Free Cash Flow
110.681.5753.0111.4-9.7842.7
Unlevered Free Cash Flow
112.5384.7859.9421.762.5358.61
Free Cash Flow After Leases
79.8382.8524.526.02-24.1788.18

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
7.8523.7626.2122.4830.0347.81
Change in Working Capital
37.2637.2613.454.48-13.9463.26